REPLReplimune Group, Inc.
$13.03+178% 1Y
$13.03
$1.7052 weeks$15.97
What is the market doing?
Mixed
1 neutral, 2 without dataRangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendRangeboundderived · Oct 8, 2026
Choppy, but holding above its 200-day average. Price is +45% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How REPL is trading
Replimune Group, Inc. is +178% over the past year while the S&P 500 is +18%: 160 points ahead of the market.
+178%
1-year return · S&P 500 +18%
- vs 200-day average
- +45%
vs 200-day average · a clear uptrend
- RSI (14)
- 50
RSI (14) · neutral
- Below its 52-week high
- 18%
Below its 52-week high
Details›
- Last close2026-10-08
- $13.03
- 1 monthS&P 500 +1.6%
- −9.7%
- 1 yearS&P 500 +18%
- +178%
- 5 yearsS&P 500 +86%
- −56%
- vs 50-day average$13.59
- −4.2%
- 52-week high
- $15.97
- 52-week low
- $1.70
- Annualised volatility
- 187%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$474K
| Year | Return |
|---|---|
| 2026 (year to date) | +34% |
| 2025 | −20% |
| 2024 | +44% |
| 2023 | −69% |
| 2022 | +0.37% |
| 2021 | −29% |
| 2020 | +166% |
| 2019 | +44% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 8 | 5 of 8 | −1.4% |
| Feb | 8 | 3 of 8 | −5.1% |
| Mar | 8 | 2 of 8 | −8.8% |
| Apr | 8 | 4 of 8 | +2.1% |
| May | 8 | 4 of 8 | +26% |
| Jun | 8 | 7 of 8 | +23% |
| Jul | 8 | 3 of 8 | −7.7% |
| Aug | 9 | 4 of 9 | +6.3% |
| Sep | 9 | 2 of 9 | −6.4% |
| Oct | 9 | 5 of 9 | +24% |
| Nov | 8 | 5 of 8 | +3.6% |
| Dec | 8 | 2 of 8 | −8.7% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.